Tc and Re labeler radioactive glycosylated octreotide derivatives
View Patent ↗Improved sst-receptor binding peptidic ligands for diagnostic and therapeutic applications in nuclear medicine are provided. The improved ligands contain either natural or unnatural amino acids or peptidomimetic structures that are modified at either the N-terminal or the C-terminal end or at both termini, a carbohydrate unit and a chelator or prosthetic group to provide a complexation of a radioisotope binding or holding the radioisotope. The sst- or SSTR-receptor binding peptidic ligands may also contain one or more multifunctional linker units optionally coupling the peptide, and/or the sugar moiety and/or the chelator and/or the prosthetic group. Upon administering the ligand to a mammal through the blood system the ligand provides improved availability, clearance kinetics, sst-receptor targeting and internalization over the non-carbohydrated ligands.
1. A somatostatin receptor (sst) binding molecule comprising:
a peptidic ligand that binds the somatostatin receptor, the peptidic ligand selected from the group consisting of octreotide and octreotate;
a carbohydrate, wherein the carbohydrate is a sugar selected from the group consisting of glucose, galactose, maltose, mannose, maltotriose, and lactose;
a chelating group that complexes a radioisotope selected from Tc and Re, the chelating group selected from the group consisting of histidine, picolylamine diacetic acid, hydroxy nicotine amide (HYNIC) and mercaptoacetyl-glycyl-glycine (MAG3); and,
a multifunctional linker unit selected from the group consisting of lysine, ornithine serine, glutamic acid, aspartic acid, O-amine serine, and mercaptopropionic acid,
wherein the multifunctional linker unit is covalenty bound to the peptidic ligand and the chelating group, and further wherein the carbohydrate is covalently bound to the multifunctional linker unit or the chelating group.
2. The molecule of claim 1 , wherein the radioisotope is an isotope of Tc.
3. The molecule of claim 1 , wherein the carbohydrate is bound to the chelating group.
4. The molecule of claim 1 , wherein the carbohydrate is bound to the multifunctional linker unit.
5. The molecule of claim 1 , wherein the carbohydrate is bound to the multifunctional linker unit or to the chelating group via a glycosidic bond.
6. The molecule of claim 1 , wherein the carbohydrate is a coupling product between the multifunctional linker unit or the chelating group, and an aldose via Amadori Reaction.
7. The molecule of claim 1 , wherein the carbohydrate is a sugar selected from the group consisting of glucose, maltose, and maltotriose.
8. The molecule of claim 1 , wherein the peptidic ligand is glycoslated at a N-terminal thereof.
9. The molecule of claim 1 , wherein the multifunctional linker unit is bound to a C-terminal of the peptidic ligand, and the carbohydrate and the chelating group are bound to the multifunctional linker unit.
10. The molecule of claim 1 , wherein the multifunctional linker unit is bound to a N-terminal of the peptidic ligand, and the carbohydrate and the chelating group are bound to the multifunctional linker unit.
11. The molecule of claim 1 , wherein the multifunctional linker unit is bound to a N-terminal of the peptidic ligand, and the chelating group is bound to the multifunctional linker unit, and the carbohydrate is bound to the chelating group.
12. The molecule of claim 1 , comprising at least two peptidic ligands.
13. The molecule of claim 12 , wherein the at least two peptidic ligands are bound to the multifunctional linker unit, and both the chelating group and the carbohydrate are bound to the multifunctional linker.
14. The molecule of claim 12 , comprising at least two carbohydrates, each bound to a N-terminal of a peptidic ligand, wherein said carbohydrates are bound to the multifunctional linker unit, and the chelating group is bound to the multifunctional linker unit.
15. The molecule of claim 12 , comprising at least two multifunctional linker units and at least two carbohydrates, wherein each carbohydrate is bound to a multifunctional linker unit, each multifunctional linker unit is bound to a N-terminal of a peptidic ligand, and each multifunctional linker unit is bound to the chelating group.
16. The molecule of claim 12 , wherein the peptidic ligands are bound to the multifunctional linker unit, the chelating group is bound to the multifunctional linker unit, and the carbohydrate is bound to the chelating group.
17. The molecule of claim 12 , wherein the carbohydrate is a sugar, and the sugar is a coupling product between an amino group of the peptidic ligand, the multifunctional linker unit, or the chelator, and an aldose via Amadori Reaction.
18. The molecule of claim 12 , wherein the carbohydrate is bound to the multifunctional linker unit, or to the chelator via a glycosidic bond.
19. A pharmaceutical compositing comprising the molecule of claim 1 , and a pharmaceutically acceptable carrier.
20. A pharmaceutical compositing comprising the molecule of claim 12 and a pharmaceutically acceptable carrier.
21. The compound [ 99m Tc]Gluc-K 0 (H)TOC.
22. The compound [ 99m Tc]Mtr-K 0 (H)TOC.
23. The compound [ 99m Tc]Gluc-K 0 (H)TOCA.
24. The molecule of claim 1 wherein the linker is lysine and the chelating group is histidine.
25. A somatostatin receptor (sst) binding molecule comprising:
an octreotide ligand that binds the somatostatin receptor;
a carbohydrate, wherein the carbohydrate is a sugar selected from the group consisting of glucose and maltotriose;
a histidine chelating group that complexes a radioisotope selected from Tc and Re; and,
a lysine multifunctional linker unit covalently coupled to the octreotide ligand and the histidine chelating group.